PAN was never a competitor to IDT. They operate in quite differnt markets. Also, it is my recollection that the AstraZeneca work was abandoned about twelve months ago when ZD 9331 proved to be a dud.
IDT has been a very fast grower over than past ten years or so but its growth rate has slowed to around 10% pa over the last couple of years and this has impacted the share price. Goos long term buy though, IMHO, and I hold a few.
any followers? pays a dividend too
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.020(5.71%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 32.0¢ | $185.3K | 554.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5298 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 54819 | 2 |
View Market Depth
| Last trade - 16.10pm 20/04/2021 (20 minute delay) ? |
 (live)
|
|||||
|
Last
32.0¢ |
Change
-0.020 ( 8.57 %) |
||||
| Open | High | Low | Volume | ||
| 34.0¢ | 34.5¢ | 32.0¢ | 82727 | ||
| Last updated 15.44pm 20/04/2021 (live) ? | |||||
| IDT (ASX) Chart |